Received Jul 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 1 | Y5X9T | IM / LA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Y004996 | SC / RA |
| TDAP | TDAP (ADACEL) | SANOFI PASTEUR | 1 | U8115AA | IM / RA |
06/11/2025 -The patient did not experience any adverse event. No symptoms to be reported. The patient received the pediatric dose of MMR + Varicella for children <13 y/o age. No treatment was necessary. The outcome was the patient is doing well.
N/A
DIABETES TYPE 2
n/a
NKDA
None